日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.

中和作用和ADCC揭示了非洲人群中不同SARS-CoV-2疫苗平台对刺突蛋白亚结构域的靶向作用存在差异。

Oluka Gerald Kevin, Katende Joseph Ssebwana, Kato Laban, Ankunda Violet, Sembera Jackson, Ejou Peter, Odoch Geoffrey, Namuyanja Angella, Kaleebu Pontiano, Serwanga Jennifer

Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak

二十年后:2000年苏丹埃博拉病毒(SUDV)疫情幸存者的长期多系统后遗症和亚临床器官功能障碍

Kaweesa, Raymond Ernest; Katende, Joseph Ssebwana; Odoch, Geoffrey; Ntabadde, Annie Daphine; Wayesu, Raymond Reuel; Mukisa, Deborah; Ejou, Peter; On Behalf Of The FiloStudy Team; Kaleebu, Pontiano; Serwanga, Jennifer

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

SARS-CoV-2 抗体反应动态和对轻症 COVID-19 的中和特征的地域差异:来自英国和乌干达的比较经验

Kato Laban, Sembera Jackson, Oluka Gerald Kevin, Katende Joseph Ssebwana, Bemanzi Juliana, Ankunda Violet, Ejou Peter, Kurshan Ashwini, Graham Carl, Seow Jeffrey, Doores Katie J, Malim Michael H, Fox Julie M, Kaleebu Pontiano, Serwanga Jennifer

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa

HIV-CORE 006 研究:在东非和南部非洲健康成年人中开展的一项双盲、随机、安慰剂对照的 1 期临床试验,评估了由 ChAdOx1 和 MVA 载体递送的 HIVconsvX 保守嵌合候选 T 细胞疫苗的安全性和广泛免疫原性。

Chanda, Chama; Kibengo, Freddie; Mutua, Michael; Ogada, Fred; Muturi-Kioi, Vincent; Akis Yildirim, Belkis M; Amondi, Mary; Baines, Andrea; Basajja, Vincent; Borthwick, Nicola; Bosire, Kefa; Chambula, Elias; Chetty, Paramesh; Chinyenze, Kundai; Chirro, Oscar; Crook, Alison; De Bont, Jan; Fernandez, Natalia; Ejou, Peter; Farah, Bashir; Glaze, Molly; Gombe, Ben; Gumbe, Anne; Hayes, Peter; Itwi, Sally; Juma, Sheba; Kabarambi, Anita; Kabengele, Chishiba; Kafeero, Paddy; Kakande, Ayoub; Kanungi, Jennifer; Kidega, William; King, Deborah; Mahira, Rose; Malogo, Roselyn; Matsoso, Mabela; Michelo, Clive; Moyo, Annie; Mugaba, Susan; Mugenya, Irene; Muhumuza, Patrick; Mujadidi, Yama F; Muriuki, Moses; Musale, Vernon; Mutua, Gaudensia; Muwowo, Meya; Mwale, Fatima; Mwangi, Irene; Nakimbugwe, Maria; Namuyanja, Angella; Nduati, Eunice; Nielsen, Leslie; Nyange, Jaquelyn; Oino, Geofrey; Okech, Brenda; Omosa-Manyonyi, Gloria; Otieno, Dan; Palmer, Shaun; Phiri, Hilda; Ramko, Kelly; Rutishauser, Rachel L; Sayeed, Eddy; Sajabi, Rose; Serwanga, Jennifer; G-T Wee, Edmund; Wenden, Claire; Cicconi, Paola; Fast, Patricia; Gilmour, Jill; Jaoko, Walter; Kaleebu, Pontiano; Kilembe, William; Kuipers, Hester; Sanders, Eduard J; Hanke, Tomáš

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

乌干达接种辉瑞-BioNTech BNT162b2疫苗后,加强免疫后针对刺突蛋白的二次IgG抗体反应较弱,这对当地的疫苗接种政策具有重要意义。

Ankunda, Violet; Katende, Joseph Ssebwana; Oluka, Gerald Kevin; Sembera, Jackson; Baine, Claire; Odoch, Geoffrey; Ejou, Peter; Kato, Laban; Kaleebu, Pontiano; Serwanga, Jennifer

Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

撒哈拉以南非洲人群中针对 Moderna mRNA-1273 疫苗的持续性 S-IgG 和 S-IgA 抗体表明,需要重新考虑加强免疫接种时间。

Serwanga, Jennifer; Ankunda, Violet; Katende, Joseph Ssebwana; Baine, Claire; Oluka, Gerald Kevin; Odoch, Geoffrey; Nantambi, Hellen; Mugaba, Susan; Namuyanja, Angella; Ssali, Ivan; Ejou, Peter; Kato, Laban; Musenero, Monica; Kaleebu, Pontiano

Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals

在撒哈拉以南非洲地区接种科兴疫苗后,可产生持续的刺突蛋白特异性IgG抗体,但基线未接种过刺突蛋白疫苗的人群中突破性感染发生率增加。

Sembera, Jackson; Baine, Claire; Ankunda, Violet; Katende, Joseph Ssebwana; Oluka, Gerald Kevin; Akoli, Christine Hermilia; Kato, Laban; Odoch, Geoffrey; Ejou, Peter; Opio, Solomon; Musenero, Monica; Kaleebu, Pontiano; Serwanga, Jennifer

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

乌干达既往感染过轻症或无症状新冠肺炎患者接种阿斯利康疫苗后抗体反应的血清阳性率和持久性:对疫苗政策的启示

Serwanga, Jennifer; Baine, Claire; Mugaba, Susan; Ankunda, Violet; Auma, Betty Oliver; Oluka, Gerald Kevin; Kato, Laban; Kitabye, Isaac; Sembera, Jackson; Odoch, Geoffrey; Ejou, Peter; Nalumansi, Amina; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano